Urotensin II in the Pathogenesis of Atherosclerosis in Cholesterol Fed Rats | ||||
Bulletin of Egyptian Society for Physiological Sciences | ||||
Article 20, Volume 31, Issue 1, December 2011, Page 285-296 PDF (312.36 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/besps.2011.35990 | ||||
View on SCiNiTO | ||||
Authors | ||||
Nahid Tahoon 1; Doaa Zineldeen2; Karima El-Desuky3 | ||||
1Department of Physiology, Faculty of Medicine-Tanta University | ||||
2Department of Biochemistry, Faculty of Medicine-Tanta University | ||||
3Department of Pathology, Faculty of Medicine-Tanta University | ||||
Abstract | ||||
Background: Atherosclerosis is the most common cause of ischemic heart diseases. Urotensin II is the most potent vasoactive peptide discovered to date with potency that overcomes that of angiotensin II, endothelin-1, serotonin and thromboxan A2. Aim: This study was undertaken to evaluate the role of exogenous urotensin II in the pathogenesis of atherosclerosis and the effect of blocking the endogenous urotensin II. Material and Methods: 32 male wistar rat were divided into 2 groups, normal control group (8 rats) and cholesterol rich diet group (24 rats).The latter is furtherly subdivided into vehicle, urotensin II and palosuran groups (each is 8 rats). In all these groups lipid profile, some inflammatory and atherosclerotic markers were measured. Histopathological examination of tissue samples from aorta and coronaries for atheromatous changes was also done in all groups. Results: Urotensin II produced significant hyperlipidemia, increased CRP and SVACM-1 and decreased NO. Foam cells and VSMC proliferation were evident histopathological findings. The effect of urotensin II was partially reversed by palosuran. Conclusion: urotensin II is an important mediator in the pathogenesis of atherosclerosis in hypercholesterolemic model. Urotensin receptor blocker may be considered as an important therapeutic target in atherosclerosis. | ||||
Statistics Article View: 104 PDF Download: 173 |
||||